Before choosing a Kova plan, ask what happens after the first prescription—not just what it costs to start. Kova advertises online access to compounded semaglutide and tirzepatide, with independent clinicians, medication delivery and a companion app. Its public documentation describes the initial approval process and several subscription options. But an important distinction appears in the terms: the first charge depends on prescription approval, while later subscription charges can occur before a subsequent clinical review or refill is completed.
This documentary review examines Kova through practical patient questions, using public pages consulted October 19, 2026. It separates the platform’s responsibilities from those of clinicians and pharmacies, preserves the advertised payment choices and identifies information to obtain before enrolling. The largest documentary limitation concerns cancellation and refunds: the available terms excerpt cuts off within the financial provisions. That gap does not establish unfavorable terms, but it prevents a complete assessment of what a patient owes or receives back when leaving a plan.
At a glance
- Who operates Kova
- LifeTech Apps Inc operates the technology platform and says it does not provide medical, pharmacy or laboratory services; independent professional groups provide clinical care.Sources: [5]
- Advertised medication access
- Kova advertises compounded semaglutide and tirzepatide, subject to clinician approval, state availability and pharmacy availability. Compounded preparations are not FDA approved.
- One-month pricing
- Semaglutide is advertised at $249 for the first month, then $299/month. Tirzepatide is advertised at $299 for the first month, then renewal at $399; that line does not repeat the renewal time unit.Sources: [4]
- Initial versus recurring charges
- The initial plan charge is captured only after clinical eligibility and an initial prescription. Later charges may precede subsequent reviews, refill requests or prescription renewals.Sources: [5]
- Included services and an exclusion
- Kova says subscriptions include consultations, prescription fulfillment, medication delivery, ongoing support and app access, without a separate medication charge. Required laboratory work costs extra.Sources: [4]
Who is responsible for your care?
Kova is the consumer-facing platform, not the entity that says it delivers every component of treatment. Its terms identify LifeTech Apps Inc as operator of the mobile app, website, accounts, portals and enrollment flows. The company expressly excludes medical, pharmacy and laboratory services from its own role. The site also lists a corporate registration number and registered office in Wilmington, Delaware; that corporate address is not evidence of a treatment location or clinical authorization.
The website says Kova works with Telegra’s provider network to connect patients with licensed professionals and compounding pharmacies. It names Laurie Mercier, MD, and nurse practitioners Kimberli Hastings, Theresa Vergara and Craig Sorkin. These are provider-published descriptions, not independently verified credentials or a promise that any named professional will handle a particular patient. Ask which professional group will provide your care, who your prescribing clinician will be and where clinical questions should go.
The site advertises access across all 50 states, but qualifies specific services by provider licensure and applicable regulation. Platform users must be at least 18, able to enter a binding contract and located in the United States. During clinical services, they must physically be in a jurisdiction where the provider is authorized. For preparation, our guide to what a program should explain before enrollment helps organize these responsibility questions without treating nationwide marketing as universal availability.
What exactly would be prescribed?
Kova advertises access to compounded semaglutide and tirzepatide when prescribed by a licensed clinician. Its intake asks about goals, medical history and a preference for injectable or oral treatment. That question does not establish which specific drug, formulation or presentation is available by each route. Before comparing an offer, request the exact medication, route, concentration, presentation and dispensing pharmacy. The consulted documentation does not establish those details for an individual order or connect every advertised price to a particular presentation.
Kova’s terms disclose that compounded medications are not FDA approved, do not receive FDA premarket review for safety, effectiveness or quality, and are not FDA-approved generics. FDA recommends compounded drugs when a person’s medical needs cannot be met by an approved drug, with a prescription and a state-licensed pharmacy. Nonapproval alone does not establish clinical inequivalence, but it also does not establish equivalence. Approval of a particular product should not be treated as approval of Kova or its pharmacies.
A useful consultation question is why the proposed preparation fits your needs and what approved alternatives were considered. Our guide to identifying the medicine behind an offer provides a framework for that conversation. FDA has received reports of measuring or administration errors involving compounded medication, including some associated with hospitalization. Ask the prescriber or pharmacist to explain the actual prescription and instructions; a review cannot supply dosing guidance or resolve an unclear label.
What happens during review—and if you already use a GLP-1?
The documented entry process begins with a questionnaire about treatment goals, medical history and preferences. A licensed clinician then reviews that information online to determine whether GLP-1 medication is appropriate. Kova says no medication ships without provider approval. The pages do not provide numerical timelines for review or establish that every consultation follows the same format. Ask whether your evaluation will involve messaging, a scheduled appointment or another format, and what additional information the clinician may need.
People already taking a GLP-1 must still complete the medical intake. Kova says a clinician will review their current treatment and history before deciding whether care can continue or transition. That is a pathway for consideration, not an assurance of the same prescription, product or uninterrupted delivery. Bring questions about how existing records will be reviewed and how the team handles coordination. The public documentation does not establish a guaranteed transition timetable or medication supply quantity.
Kova does not publish detailed BMI criteria, comorbidity requirements or medication-specific medical exclusions in the consulted material. Those omissions leave individual eligibility unresolved rather than proving that no criteria apply. NIDDK advises discussing current conditions, medicines, supplements, allergies and pregnancy plans with the treating clinician. Kova also says clinicians can order and review laboratory tests when needed, but laboratory work is not included in the program price. Ask where testing occurs, who bills for it and how results affect the next step.
Which price are you choosing?
Kova publishes separate semaglutide and tirzepatide prices for one-, three-, six- and twelve-month plans. The longer plans show a monthly amount or an upfront amount; the public wording presents alternatives, not mandatory prepayment. The table preserves those choices. It also preserves the one-month introductory charges rather than treating them as continuing prices. These are advertised prices within Kova’s compounded-medication offering; the pages do not establish the exact route, concentration or presentation associated with each line.
Kova says the subscription covers clinician consultations, prescription fulfillment, delivery, ongoing care support and full companion-app access, with no separate charge for the medication itself. Another description includes clinical review, prescription-eligibility assessment, pharmacy coordination, education and ongoing check-ins where applicable. Ask what that conditional follow-up includes for your plan. Laboratory work remains separate. Neither a plan’s duration nor its billing interval establishes how much medication arrives in each package, how many shipments occur or a minimum contractual commitment.
The site says insurance is not required and pricing is the same regardless of insurance status. It recommends asking an FSA or HSA administrator about reimbursement eligibility rather than promising reimbursement. Before selecting a longer plan, ask what the monthly option means contractually, whether any balance remains after cancellation and which services could generate additional charges. Our price questions beyond the monthly figure can help compare the advertised package with the actual checkout terms.
| Plan duration | Semaglutide | Tirzepatide |
|---|---|---|
| One month | $249 first month; then $299/month | $299 first month; then renews at $399, with no time unit repeated in that line |
| Three months | $179/month or $537 upfront | $249/month or $747 upfront |
| Six months | $149/month or $894 upfront | $229/month or $1,374 upfront |
| Twelve months | $129/month or $1,548 upfront | $199/month or $2,388 upfront |
When can Kova charge you again?
The initial enrollment protection is specific. Kova may place a temporary authorization hold on a payment method, but its terms say it will not capture the initial plan charge unless a provider determines clinical eligibility and issues the initial prescription. If no initial prescription is issued, the hold is released or voided. That is not the same as charging for treatment and later refunding it. Ask how the authorization will appear and whom to contact if its status is unclear.
Later billing works differently. The terms allow recurring charges on the scheduled billing date before completion of a subsequent review, refill request, prescription renewal or dose change. They expressly separate billing cycles from clinical reviews, prescriptions, refills and shipments. Consequently, a charge is not confirmation that a refill has been approved or dispatched. Before enrollment, ask for a concrete explanation of the next billing date, required patient actions and what happens when a clinical decision or pharmacy processing is pending.
The terms also say plan conditions shown at checkout or enrollment and confirmed in the order govern the purchase over inconsistent economic language in the general financial section, except where prohibited by law. Those checkout conditions and order confirmations were not available for this review. Save and read them before paying, especially for a multi-month option. Our questions to settle before the next charge offer a practical way to distinguish payment authorization from prescription and fulfillment responsibilities.
Which pharmacy ships it, and what if delivery goes wrong?
Kova attributes a nationwide network of 503a and 503b compounding pharmacies to Telegra MD LLC. That is a site claim, not an independent verification of pharmacy status. Its pharmacy list includes E-RxHub, Absolute Pharmacy, Southend Pharmacy, Strive Pharmacy and Pharmacy Boudreaux’s, with contact details. The list does not establish which pharmacy will fill a particular prescription. Ask for the actual dispensing pharmacy’s identity and contact information, along with who prepares the medication and who can answer product-specific questions.
Shipping and delivery dates are estimates under Kova’s terms. Clinical review, pharmacy processing, product availability and carrier operations can affect them, and no numerical arrival commitment was established in the consulted material. Patients must provide an accurate address, update it before shipment, retrieve packages promptly and store them as the pharmacy instructs. Subject to applicable law, the terms treat a shipment as delivered when the carrier confirms delivery to that address. A carrier confirmation and a satisfactory package condition are different questions.
For an approved shipping claim, Kova may arrange a replacement without an additional charge or, if replacement is not reasonably available, an applicable credit or refund under the plan terms. That is conditional, not an automatic remedy for every complaint. Dispensed products generally cannot be returned unless the pharmacy directs otherwise. FDA explicitly advises not using an injectable GLP-1 drug that arrives warm or with insufficient refrigeration and contacting the provider or dispensing pharmacy. Ask in advance how to report and document such a delivery.
What does support actually include?
Kova says its provider portal supports secure clinician messaging, refill requests, delivery tracking and billing management. The website directs questions about medication, prescriptions, refills and medical care to that portal. By contrast, support@trykova.com is designated for general companion-app inquiries. Knowing that division matters when a technical problem and a prescription question occur together. Ask whether the portal remains accessible during an account problem and which contact handles billing disputes, pharmacy coordination or difficulty reaching the clinical team.
The site advertises 24/7 patient support from the medical provider, but does not specify a guaranteed response time. Its terms also say the platform does not continuously monitor health, symptoms, medication use or activity, and that messaging and support do not make it an emergency service. Those statements can coexist: a channel may accept messages at any time without providing immediate clinical assessment. Ask what response expectations apply and what the provider tells patients to do when a concern cannot wait.
The companion app is included with every plan at no extra cost. Advertised functions include reminders, injection-site records, symptom and protein tracking, history and education, with features subject to change. These tools should not be mistaken for continuous clinical review. Privacy is another useful enrollment question: Kova’s health-data notice allows operational sharing with affiliate AM APPS LTD outside the United States, subject to stated contractual and legal obligations. Ask how app information reaches clinicians and which entities receive it.
What happens when you cancel?
Kova’s public page says patients can cancel at any time through the account page or support team. It also says access to the active medication plan, upcoming refills, clinical care through the platform and companion app ends after the paid period. Restarting may require a new clinical evaluation. Another answer describes access ending upon cancellation without that timing detail. The paid-period explanation is more specific, but written confirmation would help resolve how the policy applies to your chosen plan.
The available terms excerpt is truncated beginning within the financial provisions, preventing a complete reconstruction of the general cancellation and refund policy. This review therefore cannot establish a universal notice deadline, refund entitlement, processing timetable or remaining-payment obligation for multi-month plans. Cancellation should not be equated with a refund. Nor should a twelve-month plan name be treated, by itself, as proof either of a twelve-month minimum commitment or of freedom from one. The actual purchase terms need to answer those questions.
Before joining, request the complete applicable plan terms and ask what happens to an already submitted refill, a captured recurring charge and unused prepaid time if you cancel. Also ask how cancellation is confirmed and which date marks the end of access. Keep that answer with the order confirmation. This is especially important because Kova separates billing from prescribing and shipping: stopping one process may not explain the status of the others, and the public excerpt does not settle every boundary.
Questions & answers
Does Kova guarantee that I will receive a prescription?
No. Kova says a licensed clinician reviews the intake, history and goals and decides whether treatment is appropriate. Medication does not ship without approval, and availability depends on state, pharmacy availability and provider judgment. The initial charge is not captured unless clinical eligibility is determined and the first prescription is issued. That initial payment protection does not mean later recurring charges wait for each subsequent prescription decision.
Can I choose oral rather than injectable medication?
Kova’s questionnaire asks about injectable versus oral preferences, but the consulted pages do not establish which specific medication and formulation are actually available through each route. A preference question is not confirmation of a product offer. Ask the clinician to identify the proposed preparation, route and presentation, and ask Kova which price applies. Availability remains subject to clinical judgment, location and pharmacy availability.
Must I pay the entire longer plan upfront?
The public prices show monthly or upfront alternatives for the three-, six- and twelve-month plans, not an upfront-only requirement. For example, semaglutide’s three-month option is advertised at $179/month or $537 upfront, and tirzepatide’s at $249/month or $747 upfront. What remains unresolved is the full contractual effect of selecting monthly payments within a longer plan, including any balance after cancellation. Obtain the checkout terms before choosing.
Are laboratory tests and medication charged separately?
Kova says there is no separate medication charge within its subscription, which also covers consultations, prescription fulfillment, delivery, ongoing support and app access. Laboratory work is different: clinicians may order and review tests when needed, but patients pay separately for the tests. Ask for testing arrangements and costs before proceeding. The public descriptions do not establish a fixed follow-up schedule; ongoing check-ins are described as applicable to the case.
How do I reach someone about a refill or side effect?
Kova directs medication, prescription, refill and medical-care questions to the patient portal, where it advertises secure clinician messaging. Its app-support email is for general app inquiries. The medical provider advertises 24/7 support, but the pages do not promise a response interval. The terms explicitly exclude continuous monitoring and emergency-service functions, so clarify the provider’s instructions for time-sensitive concerns rather than assuming a submitted message receives immediate clinical review.
Will canceling automatically produce a refund?
The consulted documentation does not establish that. Kova describes cancellation through the account page or support, with access ending after the paid period, but the available terms excerpt does not contain the complete general refund provisions. An approved shipping claim may have a replacement, credit or refund remedy under applicable terms; that is not a general cancellation-refund promise. Request the full policy for your selected payment option and retain written cancellation confirmation.
Our assessment
Kova provides useful public detail about advertised prices, included services, initial prescription approval and the separation between its platform and independent clinical care. Its portal and pharmacy listings also give patients concrete starting points for understanding responsibilities. The central unresolved questions are consequential: the exact preparation and dispensing pharmacy, actual follow-up expectations, the relationship between recurring payments and refills, and complete cancellation terms for longer plans. A practical next step is to obtain those answers in writing alongside the checkout terms—not to assume the lowest monthly figure describes the whole arrangement. Kova’s documented offer is specific enough to investigate, but the available public record is not complete enough to settle every financial or care-delivery question before enrollment.
This opens the reviewed business’s website. The link is not a prescription or endorsement. Commercial relationships.
Sources & documentation
Public materials consulted October 19, 2026. Provider statements are attributed claims, not independently verified clinical outcomes. Terms can change; obtain a current written quote.